DnB Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $36.1M | Buy |
285,591
+12,484
| +5% | +$1.64M | 0.1% | 138 |
|
|
2026
Q1 | $38.1M | Buy |
273,107
+18,664
| +7% | +$2.61M | 0.14% | 118 |
|
|
2025
Q4 | $31.2M | Buy |
254,443
+9,326
| +4% | +$1.13M | 0.11% | 131 |
|
|
2025
Q3 | $27.2M | Sell |
245,117
-44,223
| -15% | -$5.03M | 0.1% | 150 |
|
|
2025
Q2 | $32.1M | Buy |
289,340
+61,277
| +27% | +$6.52M | 0.13% | 117 |
|
|
2025
Q1 | $25.6M | Sell |
228,063
-75,040
| -25% | -$7.74M | 0.12% | 137 |
|
|
2024
Q4 | $28M | Buy |
303,103
+14,626
| +5% | +$1.32M | 0.12% | 137 |
|
|
2024
Q3 | $24.2M | Sell |
288,477
-2,326
| -0.8% | -$177K | 0.11% | 148 |
|
|
2024
Q2 | $20M | Buy |
290,803
+93,165
| +47% | +$6.22M | 0.1% | 156 |
|
|
2024
Q1 | $14.5M | Sell |
197,638
-53,988
| -21% | -$4.15M | 0.08% | 190 |
|
|
2023
Q4 | $20.4M | Sell |
251,626
-58,703
| -19% | -$4.57M | 0.11% | 161 |
|
|
2023
Q3 | $23.3M | Buy |
310,329
+2,417
| +0.8% | +$186K | 0.14% | 125 |
|
|
2023
Q2 | $23.7M | Sell |
307,912
-7,725
| -2% | -$616K | 0.14% | 125 |
|
|
2023
Q1 | $26.2M | Sell |
315,637
-6,567
| -2% | -$544K | 0.17% | 118 |
|
|
2022
Q4 | $27.7M | Sell |
322,204
-5,010
| -2% | -$397K | 0.2% | 112 |
|
|
2022
Q3 | $20.2M | Sell |
327,214
-57,724
| -15% | -$3.64M | 0.16% | 133 |
|
|
2022
Q2 | $23.8M | Sell |
384,938
-20,854
| -5% | -$1.29M | 0.17% | 121 |
|
|
2022
Q1 | $24.1M | Buy |
405,792
+58,670
| +17% | +$3.75M | 0.14% | 132 |
|
|
2021
Q4 | $25.2M | Buy |
347,122
+30,308
| +10% | +$2.09M | 0.15% | 131 |
|
|
2021
Q3 | $22.1M | Sell |
316,814
-651
| -0.2% | -$45.7K | 0.14% | 135 |
|
|
2021
Q2 | $21.9M | Buy |
317,465
+7,116
| +2% | +$475K | 0.14% | 128 |
|
|
2021
Q1 | $20.1M | Sell |
310,349
-1,223,144
| -80% | -$78.9M | 0.15% | 121 |
|
|
2020
Q4 | $89.3M | Sell |
1,533,493
-288,155
| -16% | -$17.4M | 0.78% | 22 |
|
|
2020
Q3 | $115M | Buy |
1,821,648
+1,481,374
| +435% | +$103M | 1.22% | 16 |
|
|
2020
Q2 | $26.2M | Buy |
340,274
+59,282
| +21% | +$4.54M | 0.31% | 60 |
|
|
2020
Q1 | $21M | Buy |
280,992
+108,091
| +63% | +$7.47M | 0.31% | 61 |
|
|
2019
Q4 | $11.2M | Sell |
172,901
-55,705
| -24% | -$3.63M | 0.11% | 143 |
|
|
2019
Q3 | $14.5M | Sell |
228,606
-87,820
| -28% | -$5.74M | 0.16% | 106 |
|
|
2019
Q2 | $21.4M | Buy |
316,426
+25,719
| +9% | +$1.69M | 0.25% | 78 |
|
|
2019
Q1 | $18.9M | Sell |
290,707
-30,086
| -9% | -$2M | 0.22% | 84 |
|
|
2018
Q4 | $20.1M | Buy |
320,793
+33,981
| +12% | +$2.38M | 0.26% | 78 |
|
|
2018
Q3 | $22.1M | Buy |
286,812
+130,260
| +83% | +$9.84M | 0.25% | 77 |
|
|
2018
Q2 | $11.1M | Buy |
156,552
+6,600
| +4% | +$466K | 0.13% | 119 |
|
|
2018
Q1 | $11.3M | Buy |
149,952
+13,100
| +10% | +$1.04M | 0.14% | 120 |
|
|
2017
Q4 | $9.8M | Buy |
136,852
+2,370
| +2% | +$180K | 0.12% | 128 |
|
|
2017
Q3 | $10.9M | Sell |
134,482
-115,900
| -46% | -$8.86M | 0.14% | 110 |
|
|
2017
Q2 | $17.7M | Buy |
250,382
+36,400
| +17% | +$2.42M | 0.26% | 77 |
|
|
2017
Q1 | $14.5M | Sell |
213,982
-15,300
| -7% | -$1.08M | 0.23% | 86 |
|
|
2016
Q4 | $16.4M | Buy |
229,282
+3,100
| +1% | +$230K | 0.3% | 73 |
|
|
2016
Q3 | $17.9M | Buy |
226,182
+31,900
| +16% | +$2.59M | 0.35% | 68 |
|
|
2016
Q2 | $16.2M | Sell |
194,282
-37,000
| -16% | -$3.28M | 0.34% | 71 |
|
|
2016
Q1 | $21.2M | Buy |
231,282
+115,300
| +99% | +$10.4M | 0.44% | 56 |
|
|
2015
Q4 | $11.7M | Buy |
115,982
+4,200
| +4% | +$437K | 0.25% | 82 |
|
|
2015
Q3 | $11M | Hold |
111,782
| – | – | 0.27% | 81 |
|
|
2015
Q2 | $13.1M | Sell |
111,782
-15,100
| -12% | -$1.65M | 0.29% | 74 |
|
|
2015
Q1 | $12.5M | Buy |
126,882
+46,600
| +58% | +$4.73M | 0.28% | 78 |
|
|
2014
Q4 | $7.57M | Sell |
80,282
-4,400
| -5% | -$455K | 0.17% | 113 |
|
|
2014
Q3 | $9.01M | Buy |
84,682
+5,600
| +7% | +$548K | 0.2% | 92 |
|
|
2014
Q2 | $6.56M | Buy |
+79,082
| New | +$6.16M | 0.14% | 114 |
|
|
2013
Q4 | $5.34M | Sell |
71,082
-6,900
| -9% | -$480K | 0.13% | 120 |
|
|
2013
Q3 | $4.9M | Sell |
77,982
-21,518
| -22% | -$1.29M | 0.13% | 99 |
|
|
2013
Q2 | $5.1M | Buy |
+99,500
| New | +$5.19M | 0.15% | 89 |
|
Other funds holding GILD
N
DnB Asset Management's GILD Position: Q2 2026 in Review
DnB Asset Management increased its Gilead Sciences (GILD) stake by 4.6% in Q2 2026, buying an estimated $1.64M and bringing the position to 285,591 shares worth $36.1M. The position accounts for 0.1% of the portfolio, ranked #138.
DnB Asset Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $115M in Q3 2020. 1,640 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- DnB Asset Management held 285,591 shares of Gilead Sciences worth $36.1M as of Q2 2026.
- DnB Asset Management bought 12,484 Gilead Sciences shares in Q2 2026, an estimated $1.64M.
- Gilead Sciences made up 0.1% of DnB Asset Management's portfolio in Q2 2026, its #138 holding.
- DnB Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- DnB Asset Management's Gilead Sciences position peaked at $115M in Q3 2020.
- 1,640 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.